Validated panels provide a complete view of steroidogenesis using minimal sample.
Developed over a decade of dried spot testing, our patent pending device facilitates collection of patient samples and enables quantitative analyses.
Processes involving a combination of intelligent design and automation have been refined through conduct of hundreds of pediatric studies to minimize sample requirements.
Our scientists have a rich history of collaborating to invent technology, such as UHPLC, and applying those inventions to advance health through analysis.